Broyhill Asset Management's Q3 2024 investor letter reported a 6% gain, with top contributors like Philip Morris and Baxter. Baxter International Inc. had a busy quarter, selling its Kidney Care segment and facing disruptions but showing resilience.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing